Traditional pharmacology is the science of drug action in the human/animal body. We learn how the drug interacts with target molecules, example H2 receptor blockers interact with H2 receptors, and block them so histamine cannot interact with the H2 receptors of the parietal cells of the stomach. If histamine stimulation does not happen on the H2 receptors, production of HCl in stomach is reduced. This is the pharmacodynamic (what drug does to body) perspective of traditional pharmacology. Thus, H2 receptors reduce HCl acid production and give relief from pain due to acid peptic disease or stomach ulcers (break in the mucosal lining of stomach).
We also learn how the body absorbs, distributes, metabolises and gradually excretes the drug from the body (pharmacokinetics or what body does to the drug). This is the drug action and behaviour inside the body and that sums up the core of pharmacology study.
The advent of computer systems and advanced software is rewriting the study of pharmacology, from acutal living systems to experimenting on drug action in computer systems! Welcome to the world of in-silico pharmacology!!
In-silico pharmacology refers to the use of computers, advanced software, and artificial intelligence (AI) to simulate, analyze, and predict how drugs interact with biological systems. Derived from the silicon chips that power modern processors, "in silico" complements traditional in vitro (test tube) and in vivo (animal) experiments. This approach allows scientists to evaluate the efficacy, safety, and behavior of thousands of chemical compounds entirely in a virtual environment before stepping into a physical laboratory.
The use of Agentic AI software in the in-silico pharmacology practice, represents a paradigm shift from traditional predictive models and reactive generative AI (like standard chatbots) to autonomous, goal-directed digital entities. While regular generative AI responds to a single user prompt by outputting a fixed text or molecule and then stopping, agentic AI acts as an independent worker equipped with reasoning capabilities, tool integration, and long-term memory.
For example given a broad strategic goal via a prompt—such as "Find a non-imidazole agonist for the H3 receptor that can cross the blood-brain barrier"—agentic software will independently break the task down into sub-tasks. It actively writes code, queries structural databases (like ChEMBL or UniProt), executes virtual docking simulations, analyzes its own errors, and refines the molecular design continuously without human intervention until the goal is achieved.
The various AI agentic software platforms that are making drug discovery speedier & autonomous: Claude Science (by Anthropic), ChemistryAgent / BioForma Agents, Insilico Medicine Pharma.AI System (Chemistry42 / BioDesign), Schrodinger Glide and NVIDIA BioNeMo Agent Framework.
Learning how to use these agentic AI software systems as part of in-silico pharmacology is the real future of pharmacology, traditional pharmacology is migrating from lab testing of molecules to the state-of-art computer systems and software that do the work faster and more economically.
